MetaVia Inc.
MTVA
Ранг среди акций
#32895
Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a... Headquartered in Cambridge, Massachusetts, MetaVia Inc. operates as a clinical-stage biotechnology company with a core focus on discovering and commercializing novel pharmaceutical solutions for cardiometabolic disorders. Its leading investigational drug, DA-1241, a unique G-Protein-Coupled Receptor 119 agonist, is currently undergoing Phase 2a clinical trials for metabolic dysfunction-associated steatohepatitis (MASH). This follows the successful completion of Phase 1 trials for type 2 diabetes mellitus (T2DM), and the compound holds promise for use as both a standalone therapy and in combination treatments. Another significant asset, DA-1726, an innovative oxyntomodulin analogue that functions as a dual agonist for GLP-1 and glucagon receptors, is presently in preclinical development specifically for treating obesity. MetaVia's broader therapeutic pipeline also includes ANA001, a distinct oral niclosamide formulation intended for moderate COVID-19 patients; NB-01, designed to address painful diabetic neuropathy; NB-02, targeting cognitive impairment; and Gemcabene, for the management of dyslipidemia. The company engages in strategic partnerships, notably a licensing agreement with Pfizer Inc. for the research, development, manufacturing, and commercialization of Gemcabene. Additionally, a joint research collaboration with Dong-A ST and ImmunoForge supports the advancement of DA-1726. The entity adopted its current name, MetaVia Inc., in November 2024, transitioning from its former identity as NeuroBo Pharmaceuticals, Inc.
Цена акции
$1.28
Последняя синхронизация: 2026-10-20
Рыночная капитализация
$8.43M
Изменение (1 день)
4.07%
Изменение (1 год)
-21.47%
Страна
US
Торговля MetaVia Inc. (MTVA)
Категория
Healthcare
История дроблений акций MetaVia Inc. (MTVA)
Акции MetaVia Inc. (символ: MTVA) прошли через 3 дроблений.
Последнее дробление произошло Dec 21, 2023.
Одна акция MTVA, купленная до Dec 31, 2019, сейчас соответствует 0.00016666666666667 акциям MTVA.
Последнее дробление произошло Dec 21, 2023.
Одна акция MTVA, купленная до Dec 31, 2019, сейчас соответствует 0.00016666666666667 акциям MTVA.
Список дроблений акций
| Год | Дробление | Коэффициент | Суммарный коэффициент |
|---|---|---|---|
| 2023-12-21 | 1:8 | x0.125 | x0.00016666666666667 |
| 2022-09-13 | 1:30 | x0.033333333333333 | x0.0013333333333333 |
| 2019-12-31 | 1:25 | x0.04 | x0.04 |
Дробления акций аналогичных компаний или конкурентов
| Компания | Количество дроблений акций | Суммарный коэффициент | Страна |
|---|---|---|---|
| 1 | x2 |
US
|
|
| 0 | - |
US
|
|
| 1 | x3 |
AU
|
|
| 0 | - |
CH
|
|
| 0 | - |
NL
|
